Number of the records: 1
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring
- 1.Wasserbauer, M. - Hlava, S. - Drábek, J. - Šťovíček, J. - Minaříková, P. - Nedbalová, L. - Drasar, T. - Zadorová, Z. - Dolina, J. - Konečný, S. - Kojecky, V. - Koželuhová, J. - Černíková, P. - Pichlerová, D. - Kučerová, B. - Coufal, Štěpán - Keil, R.
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring.
PLoS ONE. Roč. 17, 8 August (2022), č. článku e0271299. ISSN 1932-6203. E-ISSN 1932-6203
OECD category: General and internal medicine
Impact factor: 3.7, year: 2022
Method of publishing: Open access
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271299
https://hdl.handle.net/11104/0336441
Number of the records: 1